Centessa Pharmaceuticals PLC (STU:260) Stock News, Headlines & Updates
Centessa Pharmaceuticals PLC Stock News from GuruFocus
- 1
Jun 10, 2024
Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as Chief Financial Officer and Gregory Weinhoff MD MBA, as Chief Business Officer
Marketwired • 6:00am
May 21, 2024
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
Marketwired • 8:00am
May 13, 2024
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024
Marketwired • 4:00pm
Apr 24, 2024
Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares
GlobeNewswire • 11:00pm
Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares
Marketwired • 9:00pm
Apr 23, 2024
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
Marketwired • 4:00pm
Apr 22, 2024
Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024
Marketwired • 6:00am
Mar 28, 2024
Centessa Pharmaceuticals PLC (CNTA) Earnings: A Detailed Look at Q4 and Full-Year 2023 Results
GuruFocus Research • 4:11pm
Mar 27, 2024
Centessa Pharmaceuticals PLC Chief People Officer Sells Company Shares
GuruFocus Research • 11:26pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news